- PFE -2.54%
Pfizer Marks First Revenue Growth Since COVID Revenue Peak In 2022, Lifts Annual Guidance
Yahoo Finance · 2 hours ago
Open | 31.01 |
High | 31.20 |
Low | 29.78 |
Mkt Cap | 169.66B |
P/E (TTM) | N/A |
Div & Yield | 1.68 & 5.47% |
Prev. Close | 30.72 |
52 Wk. Low | 25.20 |
52 Wk. High | 37.19 |
Related stocks
American multinational pharmaceutical corporation
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 14.88B | 19.50% ▼ |
Net Income | 3.12B | 43.80% ▼ |
Diluted EPS | 0.82 | 43.40% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.46 | - |
Q1 2024 | $0.52 | $0.82 |
Q4 2023 | -$0.22 | $0.10 |
S&P 500^GSPC | 5,435.57-27.97 (-0.51%) |
Dow 30^DJI | 40,582.06+42.13 (+0.10%) |
Nasdaq^IXIC | 17,191.52-178.68 (-1.03%) |
63.29+7.39% | |
7.17-2.18% | |
232.69-10.09% |